FDA approves world’s first dual-sensor CGM in diabetes 'breakthrough' — new Libre Duo sensor tracks ketones and blood sugar in real-time

The Libre Duo 10 Day continuous glucose monitor (CGM) from Abbott Diabetes Care.

• The FDA has approved the Libre Duo 10 Day CGM wearable
• It can continuously measure both ketones and blood sugar levels
• It’s worn by diabetics as a continuous glucose monitor (CGM)

The US Food and Drug Administration (FDA) has approved the first wearable device capable of simultaneously monitoring both ketone and bloody sugar levels, which the organization says is “a breakthrough for the safety of children and adults living with diabetes".